Filing Details
- Accession Number:
- 0000874015-14-000085
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-09-04 19:13:50
- Reporting Period:
- 2014-09-02
- Filing Date:
- 2014-09-04
- Accepted Time:
- 2014-09-04 19:13:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874015 | Isis Pharmaceuticals Inc | ISIS | Pharmaceutical Preparations (2834) | 330336973 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1564926 | R. Patrick O'neil | C/O Isis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad CA 92010 | Svp, Legal And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-09-02 | 800 | $10.29 | 4,553 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-09-02 | 800 | $40.30 | 3,753 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-09-02 | 700 | $10.29 | 4,453 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-09-02 | 700 | $40.60 | 3,753 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2014-09-02 | 1,500 | $0.00 | 1,500 | $10.29 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,983 | 2012-01-03 | 2018-01-02 | No | 4 | M | Direct |
Footnotes
- Acquired as a result of exercising a stock option pursuant to a Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 1/2/14.
- Grant of 1/3/11 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option vest and became exercisable on 1/3/12. Thereafter, the remaining shares subject to the option vest and became exercisable in 36 equal monthly installments, at the rate of 5,750 shares per year. The option shall be fully vested and exercisable on 1/3/15. The option, before the reported exercises, was exercisable as to 5,087 shares on 9/2/14.
Billionaire Hedge Funds
